Recombinant outer membrane protein A induces a protective immune response against Escherichia coli infection in mice

Applied Microbiology and Biotechnology

Volumn 99, Issue 13, 2015, Pages 5451-5460

  Guan, Qingfeng ^a,b   Wang, Xiao ^a,b,c   Wang, Xiumin ^a,b   Teng, Da ^a,b   Mao, Ruoyu ^a,b   Zhang, Yong ^a,b   Wang, Jianhua ^a,b  

^a AGRO ENVIRONMENTAL PROTECTION INSTITUTE   (China)

^b INSTITUTE OF PLANT PROTECTION   (China)

^c NORTHWEST A F UNIVERSITY   (China)

Author keywords

Escherichia coli; Immunogenicity; Mice; Outer membrane protein A; Vaccine

Indexed keywords

BACTERIA; BIOINFORMATICS; BIOLOGICAL MEMBRANES; CLONING; ENZYME ACTIVITY; IMMUNIZATION; MAMMALS; PROTEINS; RECOMBINANT PROTEINS; SALMONELLA; VACCINES;

AVERAGE MOLECULAR WEIGHT; BACTERIAL INFECTIONS; BIOINFORMATICS ANALYSIS; GRAM-NEGATIVE BACTERIA; IMMUNOGENICITY; MICE; OUTER MEMBRANE PROTEIN A; PATHOGENIC ESCHERICHIA COLI;

ESCHERICHIA COLI;

BACTERIAL VACCINE; GENOMIC DNA; OUTER MEMBRANE PROTEIN A; RECOMBINANT PROTEIN; SUBUNIT VACCINE; BACTERIUM ANTIBODY; ESCHERICHIA COLI VACCINE; OMPA OUTER MEMBRANE PROTEINS; OUTER MEMBRANE PROTEIN; RECOMBINANT VACCINE;

BACTERIUM; BIOINFORMATICS; IMMUNE RESPONSE; IMMUNIZATION; INFECTIVITY; MEMBRANE; PROTEIN; RECOMBINATION; RODENT; VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BIOINFORMATICS; CONTROLLED STUDY; CROSS PROTECTION; ESCHERICHIA COLI INFECTION; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; MOLECULAR WEIGHT; MOUSE; NEUTROPHIL; NONHUMAN; NUCLEOTIDE SEQUENCE; PHAGOCYTOSIS; PHYLOGENETIC TREE; PROTEIN EXPRESSION; SALMONELLA; SHIGELLA; WHOLE CELL; ANIMAL; BLOOD; DISEASE MODEL; DYSENTERY, BACILLARY; ESCHERICHIA COLI INFECTIONS; GENETICS; IMMUNOLOGY; SALMONELLA INFECTIONS, ANIMAL; SURVIVAL;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MUS; NEGIBACTERIA; PSEUDOMONAS; SALMONELLA; SHIGELLA;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; CROSS PROTECTION; DISEASE MODELS, ANIMAL; DYSENTERY, BACILLARY; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI VACCINES; MICE; RECOMBINANT PROTEINS; SALMONELLA INFECTIONS, ANIMAL; SURVIVAL ANALYSIS; VACCINES, SYNTHETIC;

EID: 84930755940     PISSN: 01757598     EISSN: 14320614     Source Type: Journal    
DOI: 10.1007/s00253-014-6339-6     Document Type: Article

References (56)

1. Arora A, Abildgaard F, Bushweller JH, Tamm LK (2001) Structure of outer membrane protein A transmembrane domain by NMR spectroscopy. Nat Struct Mol Biol 8(4):334–338
2. Arthur JC, Perez-Chanona E, Mühlbauer M, Tomkovich S, Uronis JM, Fan T-J, Campbell BJ, Abujamel T, Dogan B, Rogers AB (2012) Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338(6103):120–123
3. Borgatta B, Kmet-Lunaček N, Rello J (2012) E. coli O104:H4 outbreak and haemolytic–uraemic syndrome. Med Intensiva (Engl Ed) 36(8):576–583
4. Carroll MC (2004) The complement system in regulation of adaptive immunity. Nat Immunol 5(10):981–986
5. Cheng Y, Feng YJ, Luo P, Gu J, Yu S, Zhang WJ, Liu YQ, Wang QX, Zou QM, Mao XH (2009) Fusion expression and immunogenicity of EHEC EspA-Stx2A1 protein: implications for the vaccine development. J Microbiol 47(4):498–505
6. Cooper NR (1985) The classical complement pathway: activation and regulation of the first complement component. Adv Immunol 37:151–216
7. Dabo SM, Confer A, Montelongo M, York P, Wyckoff JH III (2008) Vaccination with Pasteurella multocida recombinant OmpA induces strong but non-protective and deleterious Th2-type immune response in mice. Vaccine 26(34):4345–4351
8. Dea S, Wilson L, Therrien D, Cornaglia E (2000) Competitive ELISA for detection of antibodies to porcine reproductive and respiratory syndrome virus using recombinant E. coli-expressed nucleocapsid protein as antigen. J Virol Methods 87(1–2):109–122
9. Frace AM, Klimov AI, Rowe T, Black RA, Katz JM (1999) Modified M2 proteins produce heterotypic immunity against influenza A virus. Vaccine 17(18):2237–2244
10. Garcõa-Garcõaa JC, Monteroa C, Redondoa M, Vargas M, Canales M, Boue O, Rodríguez M, Joglar M, Machado H, González IL, Valdés M, Méndez L, de la Fuente J (2000) Control of ticks resistant to immunization with Bm86 in cattle vaccinated with the recombinant antigen Bm95 isolated from the cattle tick, Boophilus microplus. Vaccine 18(21):2275–2287
11. Götze O, Mueller-Eberhard HJ (1971) The C3-activator system: an alternate pathway of complement activation. J Exp Med 134(3):90–108
12. Güereña-Burgueño F, Hall ER, Taylor DN, Cassels FJ, Scott DA, Wolf MK, Roberts ZJ, Nesterova GV, Alving CR, Glenn GM (2002) Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneously. Infect Immun 70(4):1874–1880
13. Guiral E, Mendez-Arancibia E, Soto SM, Salvador P, Fàbrega A, Gascón J, Vila J (2011) CTX-M-15–producing enteroaggregative Escherichia coli as cause of travelers’ diarrhea. Emerg Infect Dis 17(10):1950
14. Hu R, Fan ZY, Zhang H, Tong CY, Chi JQ, Wang N, Li RT, Chen L, Ding ZF, Chen LX, Tang W, Zhou X, Pu LJ, Zhu ZB, Cui YD (2013) Outer membrane protein A (OmpA) conferred immunoprotection against Enterobacteriaceae infection in mice. Israel J Vet Med 68(1):48–55
15. Huang B, Subramaniam S, Frey J, Loh H, Tan H-M, Fernandez CJ, Kwang J, Chua K-L (2002) Vaccination of ducks with recombinant outer membrane protein (OmpA) and a 41 kDa partial protein (P45N′) of Riemerella anatipestifer. Vet Microbiol 84(3):219–230
16. Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M (2010) Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin Infect Dis 51(3):286–294
17. Kawai K, Liu Y, Ohnishi K, Oshima S (2004) A conserved 37 kDa outer membrane protein of Edwardsiella tarda is an effective vaccine candidate. Vaccine 22(25–26):3411–3418
18. Koebnik R (1999) Structural and functional roles of the surface-exposed loops of the β-barrel membrane protein OmpA from Escherichia coli. J Bacteriol 181(12):3688–3694
19. Kruip J, Bald D, Boekema E, Rögner M (1994) Evidence for the existence of trimeric and monomeric Photosystem I complexes in thylakoid membranes from cyanobacteria. Photosynth Res 40(3):279–286
20. Levine MM, Edelman R (1984) Enteropathogenic Escherichia coli of classic serotypes associated with infant diarrhea: epidemiology and pathogenesis. Epidemiol Rev 6(1):31–51
21. Li C, Ye Z, Wen L, Chen R, Tian L, Zhao F, Pan J (2014) Identification of a novel vaccine candidate by immunogenic screening of Vibrio parahaemolyticus outer membrane proteins. Vaccine 32(46):6115–6121
22. Lun JS, Xia CY, Yuan CF, Zhang YL, Zhong MQ, Huang TW, Hu Z (2014) The outer membrane protein, LamB (maltoporin), is a versatile vaccine candidate among the Vibrio species. Vaccine 32(7):809–815
23. Luo Y, Dorf ME (2001) Isolation of mouse neutrophils. Curr Protoc Immunol Chapter 3, Unit 3.20
24. Ma Q, Wood TK (2009) OmpA influences Escherichia coli biofilm formation by repressing cellulose production through the CpxRA two-component system. Environ Microbiol 11(10):2735–2746
25. Maiti B, Shetty M, Shekar M, Karunasagar I, Karunasagar I (2011) Recombinant outer membrane protein A (OmpA) of Edwardsiella tarda, a potential vaccine candidate for fish, common carp. Microbiol Res 167(1):1–7
26. Martinez E, Cantet F, Fava L, Norville I, Bonazzi M (2014) Identification of OmpA, a Coxiella burnetii protein involved in host cell invasion, by multi-phenotypic high-content screening. PLoS Pathog 10(3):e1004013
27. Marzoa J, Sanchez S, Costoya L, Dieguez-Casal E, Freixeiro P, Brookes C, Allen L, Taylor S, Gorringe AR, Ferreiros CM, Criado MT (2012) Induction of immune responses by purified outer membrane protein complexes from Neisseria meningitidis. Vaccine 30(13):2387–2395
28. Morrison DC, Kline LF (1977) Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS). J Immunol 118(1):362–368
29. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S (2013) Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859):2197–2223
30. Nair MKM, Venkitanarayanan K (2007) Role of bacterial OmpA and host cytoskeleton in the invasion of human intestinal epithelial cells by Enterobacter sakazakii. Pediatr Res 62(6):664–669
31. Nieman C (1954) Influence of trace amounts of fatty acids on the growth of microorganisms. Bacteriol Rev 18(2):147–163
32. Ørskov F, Ørskov I (1992) Escherichia coli serotyping and disease in man and animals. Can J Microbiol 38(7):699–704
33. Pakalniskiene J, Falkenhorst G, Lisby M, Madsen S, Olsen K, Nielsen E, Mygh A, Boel J, Mølbak K (2009) A foodborne outbreak of enterotoxigenic E. coli and Salmonella Anatum infection after a high-school dinner in Denmark, November 2006. Epidemiol Infect 137(3):396–401
34. Perez KK, Olsen RJ, Musick WL, Cernoch PL, Davis JR, Peterson LE, Musser JM (2014) Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia. J Infect 69(3):216–225
35. Pore D, Mahata N, Pal A, Chakrabarti MK (2011) Outer membrane protein A (OmpA) of Shigella flexneri 2a, induces protective immune response in a mouse model. PLoS One 6(7):e22663
36. Potter AA, Klashinsky S, Yl L, Frey E, Townsend H, Rogan D, Erickson G, Hinkley S, Klopfenstein T, Moxley RA, Smith DR, Finlay BB (2004) Decreased shedding of Escherichia coli O157: H7 by cattle following vaccination with type III secreted proteins. Vaccine 22(3–4):362–369
37. Rasko DA, Webster DR, Sahl JW, Bashir A, Boisen N, Scheutz F, Paxinos EE, Sebra R, Chin C-S, Iliopoulos D (2011) Origins of the E. coli strain causing an outbreak of hemolytic–uremic syndrome in Germany. N Engl J Med 365(8):709–717
38. Reddy ST, Ge X, Miklos AE, Hughes RA, Kang SH, Hoi KH, Chrysostomou C, Hunicke-Smith SP, Iverson BL, Tucker PW (2010) Monoclonal antibodies isolated without screening by analyzing the variable-gene repertoire of plasma cells. Nat Biotechnol 28(9):965–969
39. Reed LJ, Muench H (1938) A simple method of estimating fifty per cent endpoints. Am J Hyg 27(3):493–497
40. Ron EZ (2006) Host specificity of septicemic Escherichia coli: human and avian pathogens. Curr Opin Microbiol 9(1):28–32
41. Ronzio RA (2003) The encyclopedia of nutrition and good health. Facts On File Inc, New York
42. Saleem M, Moore J, Derrick JP (2012) Expression, purification, and crystallization of neisserial outer membrane proteins. Neisseria meningitidis (ed by Myron Christodoulies). Methods Mol Biol 799(Chapter 6):91–106
43. Savarino SJ, Hall ER, Bassily S, Brown FM, Youssef F, Wierzba TF, Peruski L, El-Masry NA, Safwat M, Rao M (1999) Oral, inactivated, whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine: results of the initial evaluation in children. J Infect Dis 179(1):107–114
44. Shirai T, Fujii H, Ono M, Nakamura K, Watanabe R, Tajima Y, Takasawa N, Ishii T, Harigae H (2012) A novel autoantibody against fibronectin leucine-rich transmembrane protein 2 expressed on the endothelial cell surface identified by retroviralvector system in systemic lupus erythematosus. Arthritis Res Ther 14(4):R157
45. Smani Y, Fabrega A, Roca I, Sanchez-Encinales V, Vila J, Pachon J (2014) Role of OmpA in the multidrug resistance phenotype of Acinetobacter baumannii. Antimicrob Agents Chemother 58(3):1806–1808
46. Smith SG, Mahon V, Lambert MA, Fagan RP (2007) A molecular Swiss army knife: OmpA structure, function and expression. FEMS Microbiol Lett 273(1):1–11
47. Snedeker KG, Campbell M, Sargeant JM (2012) A systematic review of vaccinations to reduce the shedding of Escherichia coli O157 in the faeces of domestic ruminants. Zoonoses Public Health 59(2):126–138
48. Stoll BJ, Hansen NI, Sánchez PJ, Faix RG, Poindexter BB, Van Meurs KP, Bizzarro MJ, Goldberg RN, Frantz ID, Hale EC (2011) Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Pediatrics 127(5):817–826
49. Studier FW (2005) Protein production by auto-induction in high-density shaking cultures. Protein Expr Purif 41(1):207–234
50. Vang Petersen S, Thiel S, Jensenius JC (2001) The mannan-binding lectin pathway of complement activation: biology and disease association. Mol Immunol 38(2–3):133–149
51. Xu CX, Wang SY, Zhang ZX, Peng XX (2005) Immunogenic cross-reaction among outer membrane proteins of Gram-negative bacteria. Int Immunopharmacol 5(7–8):1151–1163
52. Yan W, Faisal SM, McDonough SP, Chang C-F, Pan M-J, Akey B, Chang Y-F (2010) Identification and characterization of OmpA-like proteins as novel vaccine candidates for leptospirosis. Vaccine 28(11):2277–2283
53. Yousef Mohamad K, Roche SM, Myers G, Bavoil PM, Laroucau K, Magnino S, Laurent S, Rasschaert D, Rodolakis A (2008) Preliminary phylogenetic identification of virulent Chlamydophila pecorum strains. Infect Genet Evol 8(6):764–771
54. Zakharian E, Reusch R (2005) Kinetics of folding of Escherichia coli OmpA from narrow to large pore conformation in a planar bilayer. Biochemistry 44(17):6701–6707
55. Zhang D, Pan W (2005) Evaluation of three Pichia pastoris-expressed Plasmodium falciparum merozoite proteins as a combination vaccine against infection with blood-stage parasites. Infect Immun 73(10):6530–6536
56. Zhu Y-G, Johnson TA, Su J-Q, Qiao M, Guo G-X, Stedtfeld RD, Hashsham SA, Tiedje JM (2013) Diverse and abundant antibiotic resistance genes in Chinese swine farms. Proc Natl Acad Sci U S A 110(9):3435–3440